The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease

Pediatric Nephrology

Volumn 27, Issue 8, 2012, Pages 1213-1219

  Kummer, Sebastian ^a   Von Gersdorff, Gero ^b   Kemper, Markus J ^c   Oh, Jun ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Disease progression; FSGS; Renal disease; Risk factor; Sex

Indexed keywords

ANDROGEN; ESTROGEN; FIBRONECTIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEAR RESPIRATORY FACTOR 1; SEX HORMONE;

CHRONIC KIDNEY DISEASE; DISEASE COURSE; GENDER; HUMAN; INCIDENCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MINIMAL CHANGE GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SEX DIFFERENCE; URINARY TRACT INFECTION;

ADULT; ANIMALS; CHILD; DISEASE PROGRESSION; FEMALE; GONADAL STEROID HORMONES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS;

EID: 84863988667     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1963-1     Document Type: Review

References (64)

1. Berg UB (2006) Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 21:2577-2582 (Pubitemid 44644534)
2. Neugarten J, Acharya A, Silbiger SR (2000) Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11:319-329 (Pubitemid 30064855)
3. Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S (2008) The impact of sex in primary glomerulone-phritis. Nephrol Dial Transplant 23:2247-2253
4. Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, Gomez LJ, Felipe O, Ramirez LA, Alarcon-Segovia D (1996) Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine 75:124-130 (Pubitemid 26159209)
5. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW (2007) Diabetic nephropathy in 27, 805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30:2523-2528 (Pubitemid 47547787)
6. Svensson M, Nystrom L, Schon S, Dahlquist G (2006) Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study. Diabetes Care 29:538-542 (Pubitemid 44115350)
7. Norris KC, Agodoa LY (2005) Unraveling the racial disparities associated with kidney disease. Kidney Int 68:914-924 (Pubitemid 43246408)
8. Carrero JJ (2010) Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 33:383-392
9. Reed E, Cohen DJ, Barr ML, Ho E, Reemtsma K, Rose EA, Hardy M, Suciu-Foca N (1992) Effect of recipient gender and race on heart and kidney allograft survival. Transplant Proc 24:2670-2671 (Pubitemid 23011640)
10. Zeier M, Dohler B, Opelz G, Ritz E (2002) The effect of donor gender on graft survival. J Am Soc Nephrol 13:2570-2576
11. Kasiske BL, Umen AJ (1986) The influence of age, sex, race, and body habitus on kidney weight in humans. Arch Pathol Lab Med 110:55-60 (Pubitemid 16011812)
12. Nyengaard JR, Bendtsen TF (1992) Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 232:194-201
13. Vereerstraeten P, Wissing M, De Pauw L, Abramowicz D, Kinnaert P (1999) Male recipients of kidneys from female donors are at increased risk of graft loss from both rejection and technical failure. Clin Transplant 13:181-186 (Pubitemid 29155247)
14. Panajotopoulos N, Ianhez LE, Neumann J, Sabbaga E, Kalil J (1990) Immunological tolerance in human transplantation. The possible existence of a maternal effect. Transplantation 50:443-445 (Pubitemid 20309866)
15. Silbiger SR, Neugarten J (1995) The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25:515-533
16. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550-557 (Pubitemid 36278371)
17. Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ (2005) Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 147:202-207 (Pubitemid 41207834)
18. Kyrieleis HA, Levtchenko EN, Wetzels JF (2007) Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 49:592-597 (Pubitemid 46654498)
19. Kyrieleis HA, Lowik MM, Pronk I, Cruysberg HR, Kremer JA, Oyen WJ, van den Heuvel BL, Wetzels JF, Levtchenko EN (2009) Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol 4:1593-1600
20. Staples AO, Greenbaum LA, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Wong CS (2010) Association between clinical risk factors and progression of chronic kidney disease in children. Clin J Am Soc Nephrol 5:2172-2179
21. Elema JD, Arends A (1975) Focal and segmental glomerular hyalinosis and sclerosis in the rat. Lab Invest 33:554-561
22. Hajdu A, Rona G (1971) The protective effect of estrogens against spontaneous pancratic islet and renal changes in aging male rats. Experientia 27:956-957
23. Lemos CC, Mandarim-de-Lacerda CA, Dorigo D, Coimbra TM, Bregman R (2005) Chronic renal failure in male and female rats. J Nephrol 18:368-373 (Pubitemid 41700098)
24. Neugarten J (2002) Gender and the progression of renal disease. J Am Soc Nephrol 13:2807-2809 (Pubitemid 35216052)
25. Tofovic SP, Dubey R, Salah EM, Jackson EK (2002) 2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol 13:2737-2747 (Pubitemid 35216043)
26. Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E (2004) Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol 15:348-358 (Pubitemid 38140775)
27. Ritz E, Schwenger V (2005) Lifestyle modification and progressive renal failure. Nephrology 10:387-392 (Pubitemid 41725516)
28. Tsimihodimos V, Dounousi E, Siamopoulos KC (2008) Dyslipi-demia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 28:958-973
29. Nguyen S, Hsu CY (2007) Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens 16:71-76
30. Westenhoefer J (2005) Age and gender dependent profile of food choice. Forum Nutr:44-51 (Pubitemid 43265035)
31. Graff-Iversen S, Thelle DS, Hammar N (2008) Serum lipids, blood pressure and body weight around the age of the menopause. Eur J Cardiovasc Prev Rehabil 15:83-88 (Pubitemid 351263260)
32. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH (2005) Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 90:1202-1209 (Pubitemid 40279255)
33. Feig DI (2009) Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens 18:526-530
34. Krishnan E, Pandya BJ, Chung L, Dabbous O (2011) Hyperuricemia and the risk for subclinical coronary atherosclerosis\-data from a prospective observational cohort study. Arthritis Res Ther 13:R66
35. Martinez-Maldonado M (2001) Role of hypertension in the progression of chronic renal disease. Nephrol Dial Transplant 16 [Suppl 1]:63-66 (Pubitemid 32492508)
36. Khoury S, Yarows SA, O'Brien TK, Sowers JR (1992) Ambulatory blood pressure monitoring in a nonacademic setting. Effects of age and sex. Am J Hypertens 5:616-623
37. McBride SM, Flynn FW, Ren J (2005) Cardiovascular alteration and treatment of hypertension: do men and women differ? Endocrine 28:199-207 (Pubitemid 43037681)
38. Munger K, Baylis C (1988) Sex differences in renal hemodynamics in rats. Am J Physiol 254:F223-231
39. Miller JA, Anacta LA, Cattran DC (1999) Impact of gender on the renal response to angiotensin II. Kidney Int 55:278-285 (Pubitemid 29004260)
40. Reckelhoff JF, Zhang H, Srivastava K, Granger JP (1999) Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34:920-923 (Pubitemid 29501324)
41. Oelkers WK (1996) Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61:166-171 (Pubitemid 26146736)
42. Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, Miller JA (2002) Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 13:446-452 (Pubitemid 34106287)
43. Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK (2005) Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care 28:1988-1994 (Pubitemid 41060974)
44. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, Schrier RW (1998) Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54:2056-2063 (Pubitemid 28533634)
45. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT (2001) Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med 161:2000-2005
46. Ahmed SB, Culleton BF, Tonelli M, Klarenbach SW, Macrae JM, Zhang J, Hemmelgarn BR (2008) Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int 74:370-376 (Pubitemid 352001252)
47. Schopick EL, Fisher ND, Lin J, Forman JP, Curhan GC (2009) Post-menopausal hormone use and albuminuria. Nephrol Dial Transplant 24:3739-3744
48. Manning PJ, Sutherland WH, Allum AR, de Jong SA, Jones SD (2003) HRT does not improve urinary albumin excretion in postmenopausal diabetic women. Diabetes Res Clin Pract 60:33-39 (Pubitemid 36299251)
49. Karl M, Berho M, Pignac-Kobinger J, Striker GE, Elliot SJ (2006) Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomer-ulosclerosis: modulation of the mesangial cell phenotype in vivo. Am J Pathol 169:351-361 (Pubitemid 44156298)
50. Klinge CM (2008) Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem 105:1342-1351
51. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, Klinge CM (2008) Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 22:609-622 (Pubitemid 351397789)
52. Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau GA, Simpkins JW (2000) Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med 223:59-66 (Pubitemid 30182658)
53. Dionne IJ, Kinaman KA, Poehlman ET (2000) Sarcopenia and muscle function during menopause and hormone-replacement therapy. J Nutr Health Aging 4:156-161
54. Flynn JM, Lannigan DA, Clark DE, Garner MH, Cammarata PR (2008) RNA suppression of ERK2 leads to collapse of mitochon-drial membrane potential with acute oxidative stress in human lens epithelial cells. Am J Physiol Endocrinol Metab 294:E589-E599 (Pubitemid 351355230)
55. Bjornstrom L, Sjoberg M (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842 (Pubitemid 40397050)
56. Koh PO (2007) Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation. Neurosci Lett 412:68-72 (Pubitemid 46038558)
57. Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, Striker GE, Xia X, Elliot S (2009) 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int 75:1194-1201
58. Doublier S, Lupia E, Catanuto P, Periera-Simon S, Xia X, Korach K, Berho M, Elliot SJ, Karl M (2011) Testosterone and 17beta-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice. Kidney Int 79:404-413
59. Ma H, Togawa A, Soda K, Zhang J, Lee S, Ma M, Yu Z, Ardito T, Czyzyk J, Diggs L, Joly D, Hatakeyama S, Kawahara E, Holzman L, Guan JL, Ishibe S (2010) Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol 21:1145-1156
60. Neugarten J, Acharya A, Lei J, Silbiger S (2000) Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol 279:F309-318
61. Guccione M, Silbiger S, Lei J, Neugarten J (2002) Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol 282:F164-169
62. Blush J, Lei J, Ju W, Silbiger S, Pullman J, Neugarten J (2004) Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice. Kidney Int 66:2148-2154 (Pubitemid 41115278)
63. Melamed ML, Blackwell T, Neugarten J, Arnsten JH, Ensrud KE, Ishani A, Cummings SR, Silbiger SR (2011) Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis. Kidney Int 79:241-249
64. Nitsch W, Thein K (1955) Therapy of the nephrotic syndrome with estradiol. Ther Ggw 94:364-366